Poor-quality tuberculosis (TB) care is now a larger barrier to reducing mortality than poor access. South Africa (SA) has one of the highest TB burdens globally. Despite ongoing efforts to improve access to testing and treatment in primary care settings, only half of South Africans with drug-susceptible TB and 22% with rifampicin-resistant TB successfully navigate TB care pathways in the public sector. Furthermore, a recent study showed that 29% of South Africans with TB symptoms first report to the private sector.
Human Sciences Research Council (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: